SIRT1 overexpression decreases cisplatin-induced acetylation of NF-κB p65 subunit and cytotoxicity in renal proximal tubule cells

Biochemical and Biophysical Research Communications

Volumn 419, Issue 2, 2012, Pages 206-210

  Jung, Yu Jin ^a   Lee, Jung Eun ^a   Lee, Ae Sin ^a   Kang, Kyung Pyo ^a   Lee, Sik ^a   Park, Sung Kwang ^a   Lee, Sang Yong ^a   Han, Myung Kwan ^a   Kim, Duk Hoon ^b   Kim, Won ^a  

^a Chonbuk National University Medical School   (South Korea)

^b National Forensic Service   (South Korea)

Author keywords

Cisplatin; Kidney; Nuclear factor kappa b; SIRT1

Indexed keywords

CISPLATIN; RESVERATROL; SIRTUIN 1; TRANSCRIPTION FACTOR RELA;

ACETYLATION; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY PROXIMAL TUBULE; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ACETYLATION; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CARBAZOLES; CELL LINE; CISPLATIN; DRUG RESISTANCE, NEOPLASM; HUMANS; KIDNEY TUBULES, PROXIMAL; PROTEIN BIOSYNTHESIS; SIRTUIN 1; STILBENES; TRANSCRIPTION FACTOR RELA;

ADENOVIRIDAE;

EID: 84862778684     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.148     Document Type: Article

References (20)

1. Ilbey Y.O., Ozbek E., Cekmen M., Simsek A., Otunctemur A., Somay A. Protective effect of curcumin in cisplatin-induced oxidative injury in rat testis: mitogen-activated protein kinase and nuclear factor-kappa B signaling pathways. Hum. Reprod. 2009, 24:1717-1725.
2. Watanabe K., Inai S., Jinnouchi K., Bada S., Hess A., Michel O., Yagi T. Nuclear-factor kappa B (NF-kappa B)-inducible nitric oxide synthase (iNOS/NOS II) pathway damages the stria vascularis in cisplatin-treated mice. Anticancer. Res. 2002, 22:4081-4085.
3. Campbell K.J., Witty J.M., Rocha S., Perkins N.D. Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-kappaB transactivation. Cancer Res. 2006, 66:929-935.
4. Chen L.F., Mu Y., Greene W.C. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 2002, 21:6539-6548.
5. Kiernan R., Bres V., Ng R.W., Coudart M.P., El Messaoudi S., Sardet C., Jin D.Y., Emiliani S., Benkirane M. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J. Biol. Chem. 2003, 278:2758-2766.
6. Viatour P., Legrand-Poels S., van Lint C., Warnier M., Merville M.P., Gielen J., Piette J., Bours V., Chariot A. Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3. J. Biol. Chem. 2003, 278:46541-46548.
7. Michan S., Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem. J. 2007, 404:1-13.
8. Kim D., Nguyen M.D., Dobbin M.M., Fischer A., Sananbenesi F., Rodgers J.T., Delalle I., Baur J.A., Sui G., Armour S.M., Puigserver P., Sinclair D.A., Tsai L.H. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 2007, 26:3169-3179.
9. Kim D.H., Jung Y.J., Lee J.E., Lee A.S., Kang K.P., Lee S., Park S.K., Han M.K., Lee S.Y., Ramkumar K.M., Sung M.J., Kim W. SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53. Am. J. Physiol. Renal. Physiol. 2011, 301:F427-435.
10. Imai S., Armstrong C.M., Kaeberlein M., Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000, 403:795-800.
11. Vaziri H., Dessain S.K., Ng Eaton E., Imai S.I., Frye R.A., Pandita T.K., Guarente L., Weinberg R.A. HSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001, 107:149-159.
12. Luo J., Nikolaev A.Y., Imai S., Chen D., Su F., Shiloh A., Guarente L., Gu W. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001, 107:137-148.
13. Motta M.C., Divecha N., Lemieux M., Kamel C., Chen D., Gu W., Bultsma Y., McBurney M., Guarente L. Mammalian SIRT1 represses forkhead transcription factors. Cell 2004, 116:551-563.
14. Yeung F., Hoberg J.E., Ramsey C.S., Keller M.D., Jones D.R., Frye R.A., Mayo M.W. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004, 23:2369-2380.
15. Tak P.P., Firestein G.S. NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 2001, 107:7-11.
16. Kim D.H., Jung Y.J., Lee A.S., Lee S., Kang K.P., Lee T.H., Lee S.Y., Jang K.Y., Moon W.S., Choi K.S., Yoon K.H., Sung M.J., Park S.K., Kim W. COMP-angiopoietin-1 decreases lipopolysaccharide-induced acute kidney injury. Kidney Int. 2009, 76:1180-1191.
17. Apraiz A., Idkowiak-Baldys J.K., Boyano M.D., Perez-Yarza G., Hannun Y.A., Asumendi A. Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells, B.M.C. Cancer 2011, 11:477.
18. Chen Y., Wang H., Yoon S.O., Xu X., Hottiger M.O., Svaren J., Nave K.A., Kim H.A., Olson E.N., Lu Q.R. HDAC-mediated deacetylation of NF-kappaB is critical for Schwann cell myelination. Nat. Neurosci. 2011, 14:437-441.
19. Zhu X., Liu Q., Wang M., Liang M., Yang X., Xu X., Zou H., Qiu J. Activation of SIRT1 by resveratrol inhibits TNF-alpha induced inflammation in fibroblasts. PLoS One 2011, 6:e27081.
20. Matsushita N., Takami Y., Kimura M., Tachiiri S., Ishiai M., Nakayama T., Takata M. Role of NAD-dependent deacetylases SIRT1 and SIRT2 in radiation and cisplatin-induced cell death in vertebrate cells. Genes Cells 2005, 10:321-332.